
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants | Neuropsychopharmacology
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBvZmNtbkRBNkRXaG5Wbm4zY0JYcHdUUHFQX0RXdFI4a0c4aWt3d0ZmaVRyZDZLNkJtQTdYWHkzT0drVlp3YWU1YmV4T19DX242ZTJUQlluNnNZQjVYNmJz?oc=5" target="_blank">Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants | Neuropsychopharmacology</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
